Dyne Therapeutics, Inc. (DYN)
NASDAQ·Healthcare·Biotechnology
$16.28
-5.02%
Mkt Cap $3.34B
Analyst Ratings
Buy
6
Hold
0
Sell
1
Price Target (31 analysts)
$35.50
Range $24.00 – $47.00
Implied Upside
+118.1%
Consensus $35.50 vs current $16.28
NASDAQ·Healthcare·Biotechnology
$16.28
-5.02%
Mkt Cap $3.34B
Buy
6
Hold
0
Sell
1
Price Target (31 analysts)
$35.50
Range $24.00 – $47.00
+118.1%
Consensus $35.50 vs current $16.28